SCHEMBL6239315

SCHEMBL6239315

NCCNCCOCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 1/20 0.46
HTR1A P08908 3/20 0.46
ADRA1D P25100 3/20 0.46
ADRA1A P35348 3/20 0.46
ADRA1B P35368 3/20 0.46
DRD2 P14416 2/20 0.44
DRD4 P21917 2/20 0.44
DRD3 P35462 2/20 0.44
SIGMAR1 Q99720 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.43
IDO1 P14902 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25985295 0.96 TSHR (0.47) TSHRSMN1; SMN2HTTHTR1AADRA1D
SCHEMBL21207996 0.93 TSHR (0.44) TSHRSMN1; SMN2HTTHTR1AADRA1D
SCHEMBL8760726 0.90 TSHR (0.61) TSHRSMN1; SMN2HTTHTR1AADRA1D
SCHEMBL11935005 0.90 SIGMAR1 (0.49) TSHRSIGMAR1
SCHEMBL7134228 0.88 TSHR (0.58) TSHRSMN1; SMN2HTTHTR1AADRA1D
SCHEMBL1923484 0.86 DRD2 (0.47) TSHRHTR1AADRA1DADRA1AADRA1B
SCHEMBL8160604 0.86 TSHR (0.47) TSHRSMN1; SMN2HTTHTR1AADRA1D
SCHEMBL31474275 0.85 TSHR (0.50) TSHRSMN1; SMN2HTTHTR1AADRA1D
SCHEMBL8154723 0.84 TSHR (0.45) TSHRSMN1; SMN2HTTHTR1AADRA1D
SCHEMBL6237709 0.82 DRD2 (0.47) HTR1AADRA1DADRA1AADRA1BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005011697-A2 SULFONAMIDE DERIVATIVES WITH ACTIVITY ON PROTEIN KINASE A AND B ASTEX THERAPEUTICS LIMITED (GB) 2005-02-10 WO claimed
WO-2005011697-A2 SULFONAMIDE DERIVATIVES WITH ACTIVITY ON PROTEIN KINASE A AND B ASTEX THERAPEUTICS LIMITED (GB) 2005-02-10 WO disclosed